Related Experiment Video
Updated: Sep 7, 2025
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Emerging nanomedical strategies for direct targeting of pediatric and adult diffuse gliomas
Christy Kolsteeg1, Esther Hulleman2, John Bianco3
1University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Abstract:
High-grade gliomas, in particularly diffuse midline glioma, H3K27-altered in children and glioblastoma in adults, are the most lethal brain tumour with a dismal prognosis. Developments in modern medicine are constantly being applied in the search for a cure, although finding the right strategy remains elusive. Circumventing the blood-brain barrier is one of the biggest challenges when it comes to treating brain tumours. The cat and mouse game of finding the Trojan horse to traverse this barrier and deliver therapeutics to the brain has been a long and hard-fought struggle. Research is ongoing to find new and feasible ways to reach specific targets in the brain, with a special focus on inoperable or recurring brain tumours. Many options and combinations of options have been tested to date and continue to be so in the search to find the most effective and least toxic treatment paradigm. Although improvements are often small and slow, some of these strategies have already shown promise, shining a light of hope that finding the cure is feasible. In this review, we discuss recent findings that elucidate promising but atypical strategies for targeting gliomas and the implications that this work has on developing new treatment regimens.
Insights
This review explores novel strategies for treating high-grade gliomas, including pediatric diffuse midline glioma and adult glioblastoma. Researchers are developing innovative methods to overcome the blood-brain barrier for more effective brain tumor treatments.
Area of Science:
- Neuro-oncology
- Cancer Therapeutics
- Drug Delivery
Background:
- High-grade gliomas, such as diffuse midline glioma (H3K27-altered) in children and glioblastoma in adults, represent aggressive brain tumors with poor prognoses.
- Current treatments face significant challenges, particularly in circumventing the blood-brain barrier to deliver therapeutic agents effectively.
Purpose of the Study:
- To review recent advancements in atypical and promising strategies for targeting gliomas.
- To discuss the implications of these findings for developing novel treatment regimens for brain tumors.
Main Methods:
- Literature review of recent research on glioma treatment strategies.
- Analysis of novel approaches focusing on overcoming the blood-brain barrier.
- Discussion of therapeutic options for inoperable or recurrent brain tumors.
Main Results:
- Several promising, albeit unconventional, strategies are emerging for glioma treatment.
- Progress is being made in developing methods to target brain tumors more effectively.
- Some strategies show potential for improved treatment efficacy and reduced toxicity.
Conclusions:
- Despite challenges, ongoing research offers hope for more effective glioma treatments.
- Novel therapeutic strategies are crucial for improving outcomes in pediatric and adult brain tumor patients.
- Overcoming the blood-brain barrier remains a key focus for advancing neuro-oncology treatments.
